OtherBehavioral Pharmacology
MDPV high-responder phenotype as a tool to evaluate candidate medications for stimulant use disorder
Michelle R. Doyle, Lindsey N Peng, Jianjing Cao, Kenner C. Rice, Amy Hauck Newman and Gregory T. Collins
Journal of Pharmacology and Experimental Therapeutics January 10, 2023, JPET-AR-2022-001419; DOI: https://doi.org/10.1124/jpet.122.001419
Michelle R. Doyle
1Department of Pharmacology, University of Texas Health Science Center at San Antonio, United States
Lindsey N Peng
1Department of Pharmacology, University of Texas Health Science Center at San Antonio, United States
Jianjing Cao
2NIH-NIDA-IRP, United States
Kenner C. Rice
3NIDA/NIH, United States
Amy Hauck Newman
4Medicinal Chemistry Section, NIDA-IRP, United States
Gregory T. Collins
5Pharmacology, University of Texas Health Science Center at San Antonio, United States

Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 385, Issue 1
1 Apr 2023
OtherBehavioral Pharmacology
MDPV high-responders to evaluate candidate medications
Michelle R. Doyle, Lindsey N Peng, Jianjing Cao, Kenner C. Rice, Amy Hauck Newman and Gregory T. Collins
Journal of Pharmacology and Experimental Therapeutics January 10, 2023, JPET-AR-2022-001419; DOI: https://doi.org/10.1124/jpet.122.001419
OtherBehavioral Pharmacology
MDPV high-responders to evaluate candidate medications
Michelle R. Doyle, Lindsey N Peng, Jianjing Cao, Kenner C. Rice, Amy Hauck Newman and Gregory T. Collins
Journal of Pharmacology and Experimental Therapeutics January 10, 2023, JPET-AR-2022-001419; DOI: https://doi.org/10.1124/jpet.122.001419
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement